Expired European patentEurope
New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide
EP 1019033 B1 · Applicant: AstraZeneca AB
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 13, 1998 and granted March 19, 2008. A European patent lasts at most 20 years from filing, so its term ended January 13, 2018.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by July 13, 2023.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledJanuary 13, 1998
PublishedJuly 19, 2000
GrantedMarch 19, 2008
Term endedJanuary 13, 2018
Application numberEP 98901616
Classification (CPC)A61P11/00 +2 more
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.